Global Biopharmaceutical CMO & CRO Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Biopharmaceutical CMO & CRO market report explains the definition, types, applications, major countries, and major players of the Biopharmaceutical CMO & CRO market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Rentschler Biotechnologie GmbH

    • AbbVie Inc

    • WuXi Biologics

    • BIOMEVA GmbH

    • Samsung BioLogics

    • Lonza

    • FUJIFILM Diosynth Biotechnologies USA, Inc

    • Binex Co, Ltd

    • Boehringer Ingelheim GmbH

    • Patheon

    • TOYOBO CO, LTD

    • Inno Biologics Sdn Bhd

    • CMC Biologics

    • ProBioGen

    • JRS Pharma

    By Type:

    • Mammalian

    • Non-mammalian

    By End-User:

    • Contract Manufacturing

    • Contract Research

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Biopharmaceutical CMO & CRO Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Biopharmaceutical CMO & CRO Outlook to 2028- Original Forecasts

    • 2.2 Biopharmaceutical CMO & CRO Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Biopharmaceutical CMO & CRO Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Biopharmaceutical CMO & CRO Market- Recent Developments

    • 6.1 Biopharmaceutical CMO & CRO Market News and Developments

    • 6.2 Biopharmaceutical CMO & CRO Market Deals Landscape

    7 Biopharmaceutical CMO & CRO Raw Materials and Cost Structure Analysis

    • 7.1 Biopharmaceutical CMO & CRO Key Raw Materials

    • 7.2 Biopharmaceutical CMO & CRO Price Trend of Key Raw Materials

    • 7.3 Biopharmaceutical CMO & CRO Key Suppliers of Raw Materials

    • 7.4 Biopharmaceutical CMO & CRO Market Concentration Rate of Raw Materials

    • 7.5 Biopharmaceutical CMO & CRO Cost Structure Analysis

      • 7.5.1 Biopharmaceutical CMO & CRO Raw Materials Analysis

      • 7.5.2 Biopharmaceutical CMO & CRO Labor Cost Analysis

      • 7.5.3 Biopharmaceutical CMO & CRO Manufacturing Expenses Analysis

    8 Global Biopharmaceutical CMO & CRO Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Biopharmaceutical CMO & CRO Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Biopharmaceutical CMO & CRO Export by Region (Top 10 Countries) (2017-2028)

    9 Global Biopharmaceutical CMO & CRO Market Outlook by Types and Applications to 2022

    • 9.1 Global Biopharmaceutical CMO & CRO Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Mammalian Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-mammalian Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biopharmaceutical CMO & CRO Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Contract Manufacturing Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Contract Research Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Biopharmaceutical CMO & CRO Market Analysis and Outlook till 2022

    • 10.1 Global Biopharmaceutical CMO & CRO Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.2.2 Canada Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.2.3 Mexico Biopharmaceutical CMO & CRO Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.2 UK Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.3 Spain Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.4 Belgium Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.5 France Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.6 Italy Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.7 Denmark Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.8 Finland Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.9 Norway Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.10 Sweden Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.11 Poland Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.12 Russia Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.3.13 Turkey Biopharmaceutical CMO & CRO Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.2 Japan Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.3 India Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.4 South Korea Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.5 Pakistan Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.6 Bangladesh Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.7 Indonesia Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.8 Thailand Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.9 Singapore Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.10 Malaysia Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.11 Philippines Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.4.12 Vietnam Biopharmaceutical CMO & CRO Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.5.2 Colombia Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.5.3 Chile Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.5.4 Argentina Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.5.5 Venezuela Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.5.6 Peru Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.5.7 Puerto Rico Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.5.8 Ecuador Biopharmaceutical CMO & CRO Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.6.2 Kuwait Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.6.3 Oman Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.6.4 Qatar Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Biopharmaceutical CMO & CRO Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.7.2 South Africa Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.7.3 Egypt Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.7.4 Algeria Biopharmaceutical CMO & CRO Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Biopharmaceutical CMO & CRO Consumption (2017-2022)

      • 10.8.2 New Zealand Biopharmaceutical CMO & CRO Consumption (2017-2022)

    11 Global Biopharmaceutical CMO & CRO Competitive Analysis

    • 11.1 Rentschler Biotechnologie GmbH

      • 11.1.1 Rentschler Biotechnologie GmbH Company Details

      • 11.1.2 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.1.4 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 AbbVie Inc

      • 11.2.1 AbbVie Inc Company Details

      • 11.2.2 AbbVie Inc Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 AbbVie Inc Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.2.4 AbbVie Inc Biopharmaceutical CMO & CRO Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 WuXi Biologics

      • 11.3.1 WuXi Biologics Company Details

      • 11.3.2 WuXi Biologics Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 WuXi Biologics Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.3.4 WuXi Biologics Biopharmaceutical CMO & CRO Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 BIOMEVA GmbH

      • 11.4.1 BIOMEVA GmbH Company Details

      • 11.4.2 BIOMEVA GmbH Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.4.4 BIOMEVA GmbH Biopharmaceutical CMO & CRO Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Samsung BioLogics

      • 11.5.1 Samsung BioLogics Company Details

      • 11.5.2 Samsung BioLogics Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Samsung BioLogics Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.5.4 Samsung BioLogics Biopharmaceutical CMO & CRO Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Lonza

      • 11.6.1 Lonza Company Details

      • 11.6.2 Lonza Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Lonza Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.6.4 Lonza Biopharmaceutical CMO & CRO Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 FUJIFILM Diosynth Biotechnologies USA, Inc

      • 11.7.1 FUJIFILM Diosynth Biotechnologies USA, Inc Company Details

      • 11.7.2 FUJIFILM Diosynth Biotechnologies USA, Inc Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 FUJIFILM Diosynth Biotechnologies USA, Inc Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.7.4 FUJIFILM Diosynth Biotechnologies USA, Inc Biopharmaceutical CMO & CRO Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Binex Co, Ltd

      • 11.8.1 Binex Co, Ltd Company Details

      • 11.8.2 Binex Co, Ltd Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Binex Co, Ltd Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.8.4 Binex Co, Ltd Biopharmaceutical CMO & CRO Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Boehringer Ingelheim GmbH

      • 11.9.1 Boehringer Ingelheim GmbH Company Details

      • 11.9.2 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.9.4 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Patheon

      • 11.10.1 Patheon Company Details

      • 11.10.2 Patheon Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Patheon Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.10.4 Patheon Biopharmaceutical CMO & CRO Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 TOYOBO CO, LTD

      • 11.11.1 TOYOBO CO, LTD Company Details

      • 11.11.2 TOYOBO CO, LTD Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 TOYOBO CO, LTD Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.11.4 TOYOBO CO, LTD Biopharmaceutical CMO & CRO Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Inno Biologics Sdn Bhd

      • 11.12.1 Inno Biologics Sdn Bhd Company Details

      • 11.12.2 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.12.4 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 CMC Biologics

      • 11.13.1 CMC Biologics Company Details

      • 11.13.2 CMC Biologics Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 CMC Biologics Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.13.4 CMC Biologics Biopharmaceutical CMO & CRO Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 ProBioGen

      • 11.14.1 ProBioGen Company Details

      • 11.14.2 ProBioGen Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 ProBioGen Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.14.4 ProBioGen Biopharmaceutical CMO & CRO Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 JRS Pharma

      • 11.15.1 JRS Pharma Company Details

      • 11.15.2 JRS Pharma Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 JRS Pharma Biopharmaceutical CMO & CRO Main Business and Markets Served

      • 11.15.4 JRS Pharma Biopharmaceutical CMO & CRO Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    12 Global Biopharmaceutical CMO & CRO Market Outlook by Types and Applications to 2028

    • 12.1 Global Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Mammalian Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Non-mammalian Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Contract Research Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Biopharmaceutical CMO & CRO Market Analysis and Outlook to 2028

    • 13.1 Global Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.2.2 Canada Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.2 UK Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.3 Spain Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.5 France Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.6 Italy Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.8 Finland Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.9 Norway Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.11 Poland Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.12 Russia Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.2 Japan Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.3 India Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.5.3 Chile Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.5.6 Peru Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.6.3 Oman Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Biopharmaceutical CMO & CRO Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Biopharmaceutical CMO & CRO

    • Figure of Biopharmaceutical CMO & CRO Picture

    • Table Global Biopharmaceutical CMO & CRO Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Biopharmaceutical CMO & CRO Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Mammalian Consumption and Growth Rate (2017-2022)

    • Figure Global Non-mammalian Consumption and Growth Rate (2017-2022)

    • Figure Global Contract Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Global Contract Research Consumption and Growth Rate (2017-2022)

    • Figure Global Biopharmaceutical CMO & CRO Consumption by Country (2017-2022)

    • Table North America Biopharmaceutical CMO & CRO Consumption by Country (2017-2022)

    • Figure United States Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Canada Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Mexico Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Table Europe Biopharmaceutical CMO & CRO Consumption by Country (2017-2022)

    • Figure Germany Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure UK Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Spain Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Belgium Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure France Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Italy Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Denmark Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Finland Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Norway Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Sweden Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Poland Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Russia Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Turkey Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Table APAC Biopharmaceutical CMO & CRO Consumption by Country (2017-2022)

    • Figure China Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Japan Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure India Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Thailand Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Singapore Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Philippines Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Table South America Biopharmaceutical CMO & CRO Consumption by Country (2017-2022)

    • Figure Brazil Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Colombia Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Chile Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Argentina Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Peru Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Table GCC Biopharmaceutical CMO & CRO Consumption by Country (2017-2022)

    • Figure Bahrain Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Oman Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Qatar Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Table Africa Biopharmaceutical CMO & CRO Consumption by Country (2017-2022)

    • Figure Nigeria Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure South Africa Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Egypt Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure Algeria Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Table Oceania Biopharmaceutical CMO & CRO Consumption by Country (2017-2022)

    • Figure Australia Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Biopharmaceutical CMO & CRO Consumption and Growth Rate (2017-2022)

    • Table Rentschler Biotechnologie GmbH Company Details

    • Table Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product Portfolio

    • Table AbbVie Inc Company Details

    • Table AbbVie Inc Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table AbbVie Inc Biopharmaceutical CMO & CRO Product Portfolio

    • Table WuXi Biologics Company Details

    • Table WuXi Biologics Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table WuXi Biologics Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table WuXi Biologics Biopharmaceutical CMO & CRO Product Portfolio

    • Table BIOMEVA GmbH Company Details

    • Table BIOMEVA GmbH Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table BIOMEVA GmbH Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table BIOMEVA GmbH Biopharmaceutical CMO & CRO Product Portfolio

    • Table Samsung BioLogics Company Details

    • Table Samsung BioLogics Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Samsung BioLogics Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table Samsung BioLogics Biopharmaceutical CMO & CRO Product Portfolio

    • Table Lonza Company Details

    • Table Lonza Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonza Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table Lonza Biopharmaceutical CMO & CRO Product Portfolio

    • Table FUJIFILM Diosynth Biotechnologies USA, Inc Company Details

    • Table FUJIFILM Diosynth Biotechnologies USA, Inc Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table FUJIFILM Diosynth Biotechnologies USA, Inc Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table FUJIFILM Diosynth Biotechnologies USA, Inc Biopharmaceutical CMO & CRO Product Portfolio

    • Table Binex Co, Ltd Company Details

    • Table Binex Co, Ltd Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Binex Co, Ltd Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table Binex Co, Ltd Biopharmaceutical CMO & CRO Product Portfolio

    • Table Boehringer Ingelheim GmbH Company Details

    • Table Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product Portfolio

    • Table Patheon Company Details

    • Table Patheon Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Patheon Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table Patheon Biopharmaceutical CMO & CRO Product Portfolio

    • Table TOYOBO CO, LTD Company Details

    • Table TOYOBO CO, LTD Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table TOYOBO CO, LTD Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table TOYOBO CO, LTD Biopharmaceutical CMO & CRO Product Portfolio

    • Table Inno Biologics Sdn Bhd Company Details

    • Table Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product Portfolio

    • Table CMC Biologics Company Details

    • Table CMC Biologics Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table CMC Biologics Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table CMC Biologics Biopharmaceutical CMO & CRO Product Portfolio

    • Table ProBioGen Company Details

    • Table ProBioGen Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table ProBioGen Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table ProBioGen Biopharmaceutical CMO & CRO Product Portfolio

    • Table JRS Pharma Company Details

    • Table JRS Pharma Biopharmaceutical CMO & CRO Sales, Price, Value and Gross Profit (2017-2022)

    • Table JRS Pharma Biopharmaceutical CMO & CRO Main Business and Markets Served

    • Table JRS Pharma Biopharmaceutical CMO & CRO Product Portfolio

    • Figure Global Mammalian Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-mammalian Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contract Research Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biopharmaceutical CMO & CRO Consumption Forecast by Country (2022-2028)

    • Table North America Biopharmaceutical CMO & CRO Consumption Forecast by Country (2022-2028)

    • Figure United States Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biopharmaceutical CMO & CRO Consumption Forecast by Country (2022-2028)

    • Figure Germany Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Biopharmaceutical CMO & CRO Consumption Forecast by Country (2022-2028)

    • Figure China Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Biopharmaceutical CMO & CRO Consumption Forecast by Country (2022-2028)

    • Figure Brazil Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Biopharmaceutical CMO & CRO Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Biopharmaceutical CMO & CRO Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Biopharmaceutical CMO & CRO Consumption Forecast by Country (2022-2028)

    • Figure Australia Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Biopharmaceutical CMO & CRO Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.